Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C

By Scagnolari Carolina   Antonelli Guido  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-08 ,pp. : 693-711

Informa Healthcare

Access to resources Recommend Favorite

Drugs in development for chronic hepatitis C: a promising future

By Pockros Paul J  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 12, 2011-12 ,pp. : 1611-1622

Informa Healthcare

Access to resources Recommend Favorite

Histological change after interferon therapy in chronic hepatitis C in view of iron deposition in the liver

By Kakizaki Satoru   Takagi Hitoshi   Ichikawa Takeshi   Abe Takehiko   Yamada Toshihiko   Suzuki Keiji   Kojima Akira   Takayama Hisashi   Takezawa Jirou   Nagamine Takeaki   Mori Masatomo  

Biological Trace Element Research, Vol. 73, Iss. 2, 2000-02 ,pp. : 151-162

Humana Press, Inc

Access to resources Recommend Favorite

Preliminary study of combination therapy with interferon-α and zinc in chronic hepatitis C patients with genotype 1b

By Nagamine Takeaki   Takagi Hitoshi   Takayama Hisashi   Kojima Akira   Kakizaki Satoru   Mori Masatomo   Nakajima Katuyuki  

Biological Trace Element Research, Vol. 75, Iss. 1-3, 2000-06 ,pp. : 53-63

Humana Press, Inc

Access to resources Recommend Favorite

Eicosapentaenoic Acid Supplementation for Chronic Hepatitis C Patients During Combination Therapy of Pegylated Interferon α-2b and Ribavirin

By Kawashima Aiko  

Lipids, Vol. 43, Iss. 4, 2008-04 ,pp. : 325-333

Springer Publishing Company

Access to resources Recommend Favorite